SYNTHESIS OF 5-S-L-CYSTEINYL-GLYCINE-L-DOPA, A NATURAL SUBSTRATE FOR SERUM AND MELANOCYTE DIPEPTIDASE

被引:6
|
作者
KAGEDAL, B [1 ]
GAWELIN, AL [1 ]
PETTERSSON, A [1 ]
机构
[1] LINKOPING UNIV HOSP,DEPT CLIN ONCOL,S-58185 LINKOPING,SWEDEN
关键词
D O I
10.1016/0003-2697(87)90216-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:167 / 174
页数:8
相关论文
共 50 条
  • [31] ENZYMATIC-SYNTHESIS OF CARBOXY-C-11-LABELED L-TYROSINE, L-DOPA, L-TRYPTOPHAN AND 5-HYDROXY-L-TRYPTOPHAN
    BJURLING, P
    ANTONI, G
    WATANABE, Y
    LANGSTROM, B
    ACTA CHEMICA SCANDINAVICA, 1990, 44 (02): : 178 - 182
  • [32] Interactions between antagonists of group 5 metabotropic glutamate receptors (mGluR5) and L-DOPA in rat models of Parkinson's disease and L-DOPA-induced dyskinesia
    Dekundy, A.
    Mela, F.
    van der Elst, M. C. J.
    Pietruszek, M.
    Danysz, W.
    Cenci, M. A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S237 - S237
  • [33] AMINOACYLEINLARGERUNG .5. UMLAGERUNG VON S-GLYCYL-N-BENZOYL-L-CYSTEINAMID IN N-BENZOYL-L-CYSTEINYL-GLYCINAMID
    BRENNER, M
    CURTIUS, HC
    KNY, M
    HELVETICA CHIMICA ACTA, 1966, 49 : 250 - &
  • [34] BIOPTERIN SYNTHESIS DEFECT - TREATMENT WITH L-DOPA AND 5-HYDROXYTRYPTOPHAN COMPARED WITH THERAPY WITH A TETRAHYDROPTERIN
    MCINNES, RR
    KAUFMAN, S
    WARSH, JJ
    VANLOON, GR
    MILSTIEN, S
    KAPATOS, G
    SOLDIN, S
    WALSH, P
    MACGREGOR, D
    HANLEY, WB
    JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (02): : 458 - 469
  • [35] STRUCTURE OF ACETONE-LYSINE-VASOPRESSIN AS ESTABLISHED THROUGH ITS SYNTHESIS FROM ACETONE DERIVATIVE OF S-BENZYL-L-CYSTEINYL-L-TYROSINE
    HAVRAN, RT
    DUVIGNEA.V
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (10) : 2696 - &
  • [36] The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease
    Vieru, Eugeniu
    Koksal, Ayhan
    Mutluay, Belgin
    Dirican, Ayten Ceyhan
    Altunkaynak, Yavuz
    Baybas, Sevim
    NEUROLOGICAL SCIENCES, 2016, 37 (05) : 743 - 747
  • [37] The relation of serum uric acid levels with l-Dopa treatment and progression in patients with Parkinson’s disease
    Eugeniu Vieru
    Ayhan Köksal
    Belgin Mutluay
    Ayten Ceyhan Dirican
    Yavuz Altunkaynak
    Sevim Baybas
    Neurological Sciences, 2016, 37 : 743 - 747
  • [39] Broad bean (Vicia faba) consumption and Parkinson's disease: a natural source of L-dopa to consider
    Ramirez-Moreno, J. M.
    Salguero Bodes, I.
    Romaskevych, O.
    Duran-Herrera, M. C.
    NEUROLOGIA, 2015, 30 (06): : 375 - 376
  • [40] SYNTHESIS OF N-[N-L-GAMMA-GLUTAMYL-L-CYSTEINYL-(CARBONYL-C-14)]-GLYCINE (GLUTATHIONE-C-14) AND OF [CYS-(CO)C-14]-(5S,6R)-LTC4
    PARENT, P
    LEBORGNE, F
    LELLOUCHE, JP
    BEAUCOURT, JP
    VANHOVE, A
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1990, 28 (06): : 633 - 644